Saturday , July 21 2018
Home / KEEP BUT DO NOT DISPLAY / Alerts / Roche stops diabetes drug development following safety concerns.

Roche stops diabetes drug development following safety concerns.

Jul 11, 2013
 

Roche stops diabetes drug development following safety concerns.

Roche Holding announced it will cease the development of its diabetes drug aleglitazar after a late-stage trial revealed the medication negatively affects the kidneys and the heart.